• Overview
    • Conditions
    • Treatments & Services
    • Physicians
    • Helicobacter pylori (Hp) is the known bacteria living in the human stomach, and the infection rate in China has reached 50-67% (1,2). As the main pathogenic factor of chronic gastritis and peptic ulcer, it is also the Class I pathogenic factor of gastric cancer. Eradication of Hp has a preventive effect on gastric cancer (3,4). Moreover, it can effectively relieve the related symptoms caused by Hp in functional dyspepsia or other stomach diseases, and improve the degree of atrophic gastritis atrophy and intestinal metaplasia.


      The eradication of H.pylori infection is based on the empirical antibiotic treatment strategy. The difficulties in the current eradication of Hp include an increasing resistance rate to many routine antibiotics, which leads to a decreasing success rate of Helicobacter pylori eradication year by year. The eradication rate of Hp in previous first-line triple therapy has decreased from more than 90% in the 1990s to less than 60% at present (3,4).


      As an infectious disease, the best eradication for H.pylori infection is individualized treatment combined with the sensitivity of H. Pylori related antibiotics. Therefore, if the drug resistance information of antibiotics can be obtained before eradication treatment, no matter the initial treatment, initial treatment failure or the failure of eradication twice (refractory H. Pylori infection), doctors tend to recommend targeted drug selection based on drug sensitivity results, especially for refractory HP infection, family history of gastric cancer, or moderate and severe gastric mucosal atrophy, intestinal metaplasia or dysplasia found in gastroscopy. In this way, not only can satisfactory eradication efficacy be achieved, but also can effectively avoid unreasonable use of antibiotics and reduce the generation of antibiotic resistance.


      References:
      [1]中华医学会消化病学分会幽门螺杆菌和消化性溃疡学组,全国幽门螺杆菌研究协作组.第五次全国幽门螺杆菌感染处理共识报告[J].中华消化杂志,2017,037(006):364-378.
      [2]Xie Y,et al. Long-term follow-up of Helicobacter pylori reinfection and its risk factors after initial eradication: a large-scale multicentre, prospective open cohort, observational study. Emerg Microbes Infect, 2020 Dec;9(1).
      [3]Malfertheiner P, Megraud F, O'Morain CA, et al. Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut 2012; 61:646.
      [4]Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. Am J Gastroenterol 2017; 112:212.

    •  

    • The Gastroenterology Department of Jiahui Health can provide a variety of routine detection methods for HP infection, including breath test, HP serum antibody, HP fecal antigen, and HP detection in gastric mucosa, etc. Moreover, we cooperates with the laboratory department of Jiahui to carry out drug sensitivity and resistance detection projects of Helicobacter pylori. In addition to routine first-line and second-line HP eradication treatment, we can also guide the plan of HP eradication based on the drug sensitivity detection results. Effectively improve the eradication rate of refractory Hp, to achieve the ideal individual therapeutic effect.

    • Languages

      Location

      Doctors

      XIA Lu, MD, PhD

      Department:
      Gastroenterology
      Inflammatory Bowel Disease Clinic
      Gastro-intestinal Polyp Clinic
      Pancreas Clinic
      Constipation Clinic
      H. Pylori Clinic
      Fatty Liver Disease Clinic
      Location:
      Jiahui International Hospital (Shanghai)
      Jiahui Health (Shanghai Yangpu)
      Languages:
      普通话,  English
      Doctor's bio

      Dr. XIA Lu is currently the director of GI Service and deputy medical director of Jiahui Medical Center (Yangpu). Prior to joining Jiahui, she was the associate chief physician at Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine. She then took on the role of director of the Endoscopy Center and administrative director of Internal Medicine at Shanghai International Medical Center. She not only has rich clinical experience in the diagnosis and treatment of common gastrointestinal diseases such as chronic gastritis, reflux esophagitis, functional gastrointestinal disease, helicobacter pylori infection, early screening for gastrointestinal tumors, inflammatory bowel disease, and pancreatic disease, but is also proficient in the diagnosis and treatment methods for gastrointestinal endoscopy.


      As the chief physician of gastroenterology, the associate professor, postgraduate research supervisor, and associate director for Diagnostics Department of Shanghai Jiao Tong University School of Medicine, Dr. Xia has been involved in the work of clinical education and research over many years. She has previously been a visiting scholar at Johns Hopkins University, Mainz University and McMaster University. She is also the visiting associate professor of the Division of Gastroenterology at John Hopkins University.

       

      Dr. Xia, is currently a member of the Chinese Society of Digestive Diseases of Chinese Medical Association (CMA), the Cooperative Group for Micro-ecology of the Chinese Society of Digestive Diseases of CMA, the Cooperative Group for Communication between Internal Medicine and Surgery, the longstanding Expert Committee for Digestive and Psychosomatic Disease of Beijing Medical Award Foundation, the Expert Committee for Health Management and Physical Examination of the Society of Endoscopy of Chinese Medical Doctor Association, the secretary-general of Inflammatory Bowel Disease of the Society of Digestive Diseases of China Association of Medical Equipment, the chairman of the education commitee of the China Crohn’s & Colitis Foundation, a member of the Expert Committee for Digestive Disease of Chinese Non-government Medical Institution, the first member of Shanghai Council of Chinese Digestive Psychosomatic Union, Dr. Xia has been a reviewer for professional journals including Chinese Journal of Digestion, Chinese Journal of Digestive Endoscopy, Chinese Journal of General Practitioners, and the Journal of Digestive Diseases. She is also the editorial board member for NEJM that is the Chinese edition of the New England Journal of Medicine, a member of WGe-WGN Editorial Board.


      License no. :110310000002958

      Read More

      William CAO, MD, PhD

      Department:
      Gastroenterology
      Inflammatory Bowel Disease Clinic
      Gastro-intestinal Polyp Clinic
      Anorectal disease clinic
      GI GERD Clinic
      Pancreas Clinic
      Biliopancreatic endoscopy clinic
      H. Pylori Clinic
      Fatty Liver Disease Clinic
      Location:
      Jiahui International Hospital (Shanghai)
      Languages:
      普通话,  English
      Doctor's bio

      Dr. William CAO is a gastroenterologist at Jiahui Health. Dr. Cao obtained his bachelor's degree in Clinical Medicine from Nanjing Medical University in 2001 and his PhD in Gastroenterology from Xiangya School of Medicine, Central South University in 2008. Prior to joining Jiahui Health, he served as an associate chief physician and postgraduate supervisor in the Department of Gastroenterology of Nanjing First Hospital, Nanjing Medical University. He was once a visiting scholar at National Cancer Center Hospital, Japan.


      Dr. Cao has 18 years of clinical experience in digestive diseases. His main practices include but are not limited to the following conditions: 

      • Digestive diseases, including gastroesophageal reflux disease, helicobacter pylori infection, chronic gastritis, peptic ulcer, functional gastrointestinal disease, inflammatory bowel disease, liver dysfunction, fatty liver, common bile duct stone and pancreatic disease.
      • Endoscopic procedures, including endoscopic mucosal resection (EMR) for gastrointestinal polyps, endoscopic screening and treatment of early gastrointestinal tumor, endoscopic retrograde cholangiopancreatography (ERCP), endoscopic ultrasonography (EUS) and fine needle aspiration (FNA), endoscopic variceal ligation (EVL) and endoscopic sclerotherapy (EVS) for gastroesophageal varices.


      Dr. Cao has published more than 10 papers as the first author or corresponding author. He led a project supported by Nanjing Medical Science and Technology Development Foundation and a key project supported by Nanjing Medical University Science and Technology Development Foundation. As a principal researcher, he participated in a project sponsored by the National Natural Science Foundation of China.


      License no. :110320100016883

      Read More

      Michael SUN, MD, PhD

      Department:
      Gastroenterology
      Gastro-intestinal Polyp Clinic
      Anorectal disease clinic
      Biliopancreatic endoscopy clinic
      H. Pylori Clinic
      Fatty Liver Disease Clinic
      Location:
      Jiahui International Hospital (Shanghai)
      Languages:
      普通话,  English
      Doctor's bio

      Dr. Michael SUN is now a gastroenterologist at Jiahui Health. Before joining Jiahui, he served as deputy chief physician in the Department of Gastroenterology in Wuxi NO.2 Hospital affiliated to Nanjing Medical University and Putuo Hospital affiliated to Tongji University. He has intensive experience in various Gastroenterology disease; his major specialty is Endoscopy procedure therapy, including GI Endoscopy procedure (Gastroscopy & Colonoscopy screening); GI polypectomy therapy (EMR); GI early cancer diagnosis and treatment (ESD); Endoscopic Ultrasound procedure (EUS); Duodenoscopy (Gallbladder and Pancreatic ERCP procedure). He has published 15 papers in core journals or above (as the first author).


      License no. :110320200013583

      Read More

      HUANG Qin, MD

      Department:
      Gastroenterology
      Inflammatory Bowel Disease Clinic
      Gastro-intestinal Polyp Clinic
      Anorectal disease clinic
      GI GERD Clinic
      Constipation Clinic
      H. Pylori Clinic
      Location:
      Jiahui International Hospital (Shanghai)
      Languages:
      普通话,  English
      Doctor's bio

      Dr. HUANG Qin, practice as a gastroenterologist at Jiahui Health. Dr. Huang received his medical degree from Ganna university School of Medicine in 2006, and she received her gastroenterologist professional license in 2013. Before joining Jiahui Health, Dr. Huang was a gastroenterologist in one of major private hospital Delta health in Shanghai, she has practiced gastroenterology and endoscopy for 10 years and has gained extensive experience in the diagnosis and treatment of common GI diseases as well as GI chronic disease management. She specializes in Endoscopic screening procedure, focus on early cancer diagnosis and treatment, such as polypectomy.


      License no. :110310000056190

      Read More

      Jane SONG, MD

      Department:
      Gastroenterology
      Gastro-intestinal Polyp Clinic
      Anorectal disease clinic
      GI GERD Clinic
      Constipation Clinic
      H. Pylori Clinic
      Location:
      Jiahui International Hospital (Shanghai)
      Jiahui Health (Shanghai Yangpu)
      Languages:
      普通话,  English
      Doctor's bio

      Dr. Jane SONG is gastroenterologist in Jiahui international hospital. She graduated from Fudan University and received clinical training as a resident physician in Huashan Hospital. Dr. Song then Joined Affiliated Hospital of Hangzhou Normal University and the 455th Hospital of the People's Liberation Army as GI physician. With more than ten years of clinical experience in gastroenterology, Dr. SONG’s clinical specialty are mainly focus on digestive system disease, such as gastroesophageal reflux disease, peptic ulcer, Helicobacter pylori infection, functional gastrointestinal disease, inflammatory bowel disease, etc. Meanwhile, Dr. SONG has extensive experience in endoscopy therapy including early gastrointestinal cancer screening, gastrointestinal polyp removal, esophagus/stomach foreign body removal, gastric lithotripsy, endoscopic hemostasis for gastrointestinal bleeding, endoscopic mucosal resection (EMR), etc. She published many academic studies in domestic and foreign journals, including SCI indexed.


      License no. :110654024000075

      Read More

    CONTACT US

    Follow us

    Jiahui's Partners

    Copyright © 2017 by Jiahui,Inc. All rights reserved 沪ICP备15019023号-1 | 沪公网安备 31010402004841 号

    2021-06-01
    • Scan the QR code to follow
      Expat account Jiahui Health